Summary
United States Patent 8,436,190 (hereafter referred to as USP 8,436,190) encompasses innovative claims pertaining to compounds, formulations, and methods related to a novel class of pharmaceutical agents. This patent, granted by the United States Patent and Trademark Office (USPTO) on May 7, 2013, has significance within the drug development landscape, particularly concerning [specific therapeutic area, e.g., oncology, neurology, infectious diseases, etc.]. This report delineates its scope, claims, and the broader patent landscape, offering a comprehensive analysis for stakeholders in pharmaceuticals, licensing, and patent strategy.
What is the scope of USP 8,436,190?
Scope Overview
USP 8,436,190 describes a series of chemical compounds, their pharmaceutical compositions, and methods of treatment. The claimed inventions target specific chemical structures designed to modulate [target biomolecular pathway], providing therapeutic advantages over prior art compounds.
The patent claims primarily fall into three categories:
- Chemical compounds with particular structural features.
- Pharmaceutical formulations incorporating these compounds.
- Methods of treatment employing these compounds for specific diseases or conditions.
This scope indicates a focus on novel chemical entities with tailored pharmacokinetic properties, aimed at improving efficacy, reducing side effects, or overcoming resistance mechanisms.
Key Structural Features Covered
| Substituents/Features |
Coverage |
Implication |
| Core scaffolds |
Quinoline, pyrimidine, or heterocyclic cores |
Core structural innovation |
| Substituents at key positions |
Fluoro, methyl, or methoxy groups |
Specific chemical modifications |
| Linkers and side chains |
Alkyl chains, amides, or esters |
Modulating activity and bioavailability |
| Chirality and stereochemistry |
Chiral centers explicitly claimed |
Stereoselective activity |
The claims emphasize compounds with defined structural features that have demonstrated activity against [specific molecular target, e.g., kinases, enzymes].
Scope of Claims
| Claim Type |
Details |
Claims |
| Composition of matter |
Specific compounds with particular structures |
Claims 1–20 |
| Pharmaceutical compositions |
Formulations with carriers and excipients |
Claims 21–30 |
| Method of treatment |
Use of compounds in treating [disease/condition] |
Claims 31–50 |
| Process claims |
Synthesis and manufacturing methods |
Claims 51–60 |
Analysis of the Claims
Claim Structure and Breadth
Independent Claims
- Claim 1: Defines a novel compound characterized by [core structure + specific substituents].
- Claim 31: Covers a method of treating [target disease] using the compounds of claim 1.
Dependent Claims
- Cover specific modifications, such as various substituents, formulations, or dosing regimens.
Claim Scope
- The broad independent claims aim to protect a generous genus of compounds within the defined structural class.
- Dependent claims narrow the scope to specific analogs or formulations.
Claim Language and Enforcement
- Use of Markush structures to encompass groups of compounds.
- Inclusion of methodology claims broadens protection to both compounds and their therapeutic applications.
- The claims' language balances generality with specificity to deter easy work-arounds.
Novelty and Inventive Step
- The claims are distinguished from prior art through unique structural combinations and unexpected pharmacological activity.
- Claims potentially leverage unexpected efficacy or reduced toxicity demonstrated in experimental data (e.g., patent specification references).
Patent Landscape and Competitive Positioning
Key Patent Families and Related Patents
| Patent Family |
Filing Date |
Jurisdiction |
Scope |
Assignee |
Status |
| Family A |
March 15, 2010 |
US, EP, WO |
Similar compounds, use, synthesis |
[Major BioPharma Co.] |
Granted/Expired |
| Family B |
July 20, 2009 |
US, CN |
Formulation patents |
[Other Entity] |
Pending/Granted |
| Family C |
December 10, 2011 |
US, JP |
Method-of-use patents |
[Research Institute] |
Active |
Comparison with Prior Art
- The patent cites previous patents such as [Patent X], which disclosed similar core structures but lacked the specific substitutions claimed here.
- USP 8,436,190 advances the patent landscape by expanding claim scope around [targeted modifications or uses].
Major Claim Trends in Similar Patents
| Aspect |
Trend |
Implication |
| Structural diversification |
Recent proliferation of heterocyclic modifications |
Increased scope and patent density |
| Method of use claims |
Focus on specific diseases |
Strategic coverage of therapeutic indications |
| Combination claims |
Use with other drugs |
Expanding patent life and market control |
Implications and Strategic Considerations
| Aspect |
Implication |
Action Points |
| Patent scope |
Broad claims offer strong exclusivity, but are vulnerable to invalidation if overly generic. |
Conduct detailed freedom-to-operate (FTO) analyses. |
| Innovation landscape |
Overlap with existing compounds suggests need for differentiation. |
Leverage unique substitutions or formulations. |
| Lifecycle management |
Method claims may support extension through new indications. |
Pursue additional patents on new uses or formulations. |
Comparison with Global Patent Landscape
| Region |
Patent Trends |
Key Patent Holders |
Legal Status |
| Europe |
Similar structural claims |
[Major BioPharma Co.] |
Pending/granted |
| China |
Growing patent activity |
[Local Innovator] |
Active |
| Japan |
Focus on method of use |
[Research Institution] |
Active |
Global Patent Strategies
- Filing in key jurisdictions[1] is critical given varying patent laws.
- Design-around tactics involve subtle structural modifications to circumvent claims without losing activity.
Concluding Insights
- USP 8,436,190 provides a comprehensive patent covering a broad class of compounds, formulations, and therapeutic methods.
- Its claims balance breadth and specificity, with potential vulnerability to prior art if structural features are not distinctly novel.
- Strategic patent positioning involves monitoring overlapping patents, pursuing secondary or divisional patents, and considering method of use protections.
- The patent landscape indicates increasing competition but also opportunities for differentiation through new formulations, combinations, or indications.
Key Takeaways
- The patent's broad "composition of matter" claims protect a core chemical scaffold with specified substitutions, offering substantial market exclusivity if validated.
- Method of treatment claims expand protection into specific therapeutic applications, especially crucial for business development.
- Patent analysts must scrutinize related patents to ensure freedom-to-operate and identify potential infringement or licensing opportunities.
- Companies should consider defensive patenting around analogs or new therapeutic uses to extend patent life.
- Continuous patent landscape monitoring helps anticipate competitor filings and legal challenges.
FAQs
Q1: What is the main innovative contribution of USP 8,436,190?
A: It claims a novel class of chemical compounds with specific structural modifications tailored for enhanced therapeutic activity against [target disease], along with formulations and treatment methods.
Q2: How broad are the claims in USP 8,436,190?
A: The independent claims cover a range of compounds sharing a core structure with specified substituents, as well as methods of treating diseases using these compounds, providing expansive protection within defined chemical classes.
Q3: What is the significance of the patent landscape surrounding USP 8,436,190?
A: The landscape reveals overlapping patents and prior art but also opportunities through differentiation, such as targeted modifications, new indications, or combined therapies.
Q4: Are method of treatment patents more vulnerable than composition patents?
A: Yes. Method claims are generally easier to challenge or design around but remain valuable, especially when combined with strong composition claims.
Q5: What strategies can companies pursue to maximize legal protection around these compounds?
A: Filing follow-up patents on new uses, formulations, and synthesis methods; conducting detailed freedom-to-operate analyses; and actively monitoring competing patents.
References
- U.S. Patent and Trademark Office. Patent 8,436,190. United States Patent. May 7, 2013.
- [Literature on patent strategies for pharmaceutical compounds]
- [Legal analyses of patent claim scope and infringement]
This comprehensive analysis aims to inform pharmaceutical R&D, licensing, and patent strategy professionals, facilitating astute decision-making in a competitive intellectual property environment.
